| Literature DB >> 35694223 |
Fatemeh Kabirian1, Petra Mela2, Ruth Heying1.
Abstract
Smart materials are able to react to different stimuli and adapt their shape to the environment. Although the development of 3D printing technology increased the reproducibility and accuracy of scaffold fabrication, 3D printed scaffolds can still be further improved to resemble the native anatomy. 4D printing is an innovative fabrication approach combining 3D printing and smart materials, also known as stimuli-responsive materials. Especially for cardiovascular implants, 4D printing can promisingly create programmable, adaptable prostheses, which facilitates implantation and/or create the topology of the target tissue post implantation. In this review, the principles of 4D printing with a focus on the applied stimuli are explained and the underlying 3D printing technologies are presented. Then, according to the type of stimulus, recent applications of 4D printing in constructing smart cardiovascular implants and future perspectives are discussed.Entities:
Keywords: 3D printing; 4D printing; biomaterials; bioprinting; cardiac patches; cardiovascular; vascular grafts; vascular stents
Year: 2022 PMID: 35694223 PMCID: PMC9174528 DOI: 10.3389/fbioe.2022.873453
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Schematic illustration of 3D printing and 4D printing approaches. Physical, chemical, and biological stimuli are summarized in the key box including temperature, light, electrical and magnetic field, moisture, pH, ions, and cell traction.
FIGURE 2The schematic representation of 3D printing and bioprinting techniques. 3D printing techniques such as fused filament fabrication (FFF), digital light processing (DLP), selective laser melting (SLM), and melt electrowriting (MEW). FFF is an extrusion approach for melted thermoplastic polymers. DLP is applicable for photopolymers. In SLM which is applicable for powder materials, a laser beam fuses the particles. MEW is a nozzle-based method to extrude solvent-free polymer fibers in a high-voltage field. Bioprinting methods are including micro-extrusion, inkjet, and laser-assisted bioprinting. Micro-extrusion works based on pneumatic or mechanical (piston or screw) dispension. Inkjet printing ejects droplets of material by thermal or piezoelectric pressure. In laser-assisted printing, the material absorbs the laser energy and is ejected as a jet of bioink. Reproduced with permission of Touri et al. (2019).
FIGURE 3Fabrication steps and investigations of 4D printed vascular grafts. (A) Schematic representation of the 3D printing of vascular grafts from UV curable composite ink composed of crystalline linear chain and crosslinked network and the structural changes during this process. (B) Photograph (left) and microscopic image (right) of two different inner/outer diameters of printed vascular grafts with the same length of 10 mm. (C) Stretching and compressing of vascular conduits by thermal stimulation at 70°C (above PCL Tm) to the temporary shape with half of the initial diameter and shape recovery after cooling down (below PCL Tm). (D) Three healing cycles of the printed structures by cooling down in the air after heating at 80°C for 20 min (E) Scanning electron microscopy (SEM) observation of the scratched and healed part of the sample. (F) (1) The 4D printed blood vessel (2) was cut to be prepared for implantation. (3) By clamping the bleeding was stopped. (4) Implantation of the 4D printed graft in the crack region. (5) Shape recovery and attachment of the 4D printed graft to the vasculature by heating. (6) Blood circulation after vascular connection. Reproduced with permission of Kuang et al. (2018).
FIGURE 4Design, fabrication, and in vivo studies of 4D cardiac patches. (A) Myofiber orientation of the left ventricular wall from +60° to −60° which rotates (B) left-handed from epicardium to the right-handed in the endocardium. (C) Cardiac curvatures in diastole and systole. (D) CAD design of the 3D heart architecture during stretching. (E) Geometric model of fibers in printed patches in which α represents the angle and L the length of the fiber, D the special displacement, and κ 1 and 2 the ventricular curvature in systole and diastole, respectively. (F) Implanted 4D printed patch and (G) MI heart model after 4 months of implantation. (H) Firm attachment of an implanted cellularized patch after 3 weeks (I) H&E staining of the cellularized patch after 3 weeks of implantation indicating a high concentration of cells (yellow arrows and scale bar: 400 µm). (J) Fluorescent image of GFP + hiPSC-CMs after 3 weeks of implantation demonstrating high viability and engraftment (scale bar: 100 µm). (K) Immunofluorescence staining of cTnIand vWf verifying the presence of hiPSC-CMs and hECs on the cellularized patches after 3 weeks of implantation (scale bar: 100 µm). (L) Comparison of infarct size indicated by yellow circles, mouse model control (left, ∼ 8.4 ± 1.1%) and with patch implantation (right, ∼ 3.8 ± 0.7%) after 10 weeks. (M) MRI imaging of the heart with implanted patch after 10 weeks. Reproduced from Cui et al. (2020).
4D printed cardiovascular implants classified according to the stimulus.
| 3D Printing strategy | Ink | Stimulus | Application | Ref |
|---|---|---|---|---|
|
| ||||
| FFF | PGDA | Temperature | Shape memory vascular graft |
|
| PSTS | SOEA | Temperature | Shape memory thin film for integration with the damaged heart tissue and minimizing the invasiveness of the operation |
|
| DIW | AUD, BA, PCL, and fumed silica nanoparticles | Temperature | Self-healing and shape memory vascular grafts able to heal microcracks and notched gaps eliminating the need for surgical suturing |
|
| DIW | βCD, PCL, and paclitaxel | Temperature | Biodegradable vascular stents to be implanted in a compressed size and recover the target shape after deployment to reduce the surgical damage |
|
| DLP | PEGDA and graphene nanoplatelets | Light | Adjustable scaffolds with the curvatures of the heart after MI making them an appropriate personalized product for commercialization |
|
| Beam-scanning stereolithography | GelMA and PEGDA | Light | Cardiac patches to attach to the epicardium after MI |
|
| FFF | PLA and Fe3O4 magnetic nanocomposite | Magnetic fields | Biodegradable patient-specific left atrial appendage occluders |
|
| DIW | PLA and Fe3O4 magnetic nanocomposite | Magnetic fields | Personalized self-expandable biodegradable vascular stents |
|
| FFF | Commercially available flexible thermoplastic copolyester elastomer | Temperature | Self-expandable biodegradable vascular stents |
|
| FFF | PLA | Temperature | Self-expandable biodegradable vascular stents |
|
| DIW | Poly(d,l-lactide-co-trimethylene carbonate) | Temperature | Self-expandable biodegradable vascular stents |
|
| FFF | PLA | Temperature | Self-expandable biodegradable vascular stents |
|
|
| ||||
| FFF | Methacrylated alginate and hyaluronic acid | Calcium ions | Biodegradable vascular grafts with internal diameter of 20 µm |
|
|
| ||||
| - | Parylene microplates and cells | Cell traction force | Self-folding cell-laden microstructures |
|
FFF, fused filament fabrication; PGDA, poly(glycerol dodecanoate) acrylate; PSTS, photolithographic-stereolithographic-tandem strategy; SOEA, soybean oil epoxidized acrylate; AUD, aliphatic urethane diacrylate; BA, n-butyl acrylate; PCL, polycaprolactone; βCD, β-cyclodextrin; DLP, digital light processing; PEGDA, polyethylene glycol diacrylate; MI, myocardial infarction; GelMA, gelatin methacrylate; PLA, polylactic acid.